Clinical trials
Phase 3 Glucose Metabolism Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2006 | 7 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 14 |
| Eli Lilly and Company | 6 |
| AstraZeneca | 5 |
| Pfizer | 2 |
| Denver Health and Hospital Authority | 1 |
| Orexigen Therapeutics, Inc | 1 |
| Rezolute | 1 |
| Ultragenyx Pharmaceutical Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 31 |
| Diabetes Mellitus, Type 2 | 28 |
| Diabetes Mellitus | 26 |
| Metabolic Diseases | 17 |
| Endocrine System Diseases | 15 |
| Dyslipidemias | 13 |
| Diabetes Mellitus, Lipoatrophic | 5 |
| Body Weight | 3 |
| Nutrition Disorders | 3 |
| Obesity | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.